SE503179C2 - Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför - Google Patents

Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför

Info

Publication number
SE503179C2
SE503179C2 SE8900565A SE8900565A SE503179C2 SE 503179 C2 SE503179 C2 SE 503179C2 SE 8900565 A SE8900565 A SE 8900565A SE 8900565 A SE8900565 A SE 8900565A SE 503179 C2 SE503179 C2 SE 503179C2
Authority
SE
Sweden
Prior art keywords
alkyl
formula
hydrogen
cyclohexyl
methyl
Prior art date
Application number
SE8900565A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900565D0 (sv
SE8900565L (sv
Inventor
William T Han
John J Wright
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8900565D0 publication Critical patent/SE8900565D0/xx
Publication of SE8900565L publication Critical patent/SE8900565L/xx
Publication of SE503179C2 publication Critical patent/SE503179C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
SE8900565A 1988-02-18 1989-02-17 Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför SE503179C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/156,865 US4824959A (en) 1988-02-18 1988-02-18 Intermediates for antihypercholesterolemic tetrazole compounds

Publications (3)

Publication Number Publication Date
SE8900565D0 SE8900565D0 (sv) 1989-02-17
SE8900565L SE8900565L (sv) 1989-08-19
SE503179C2 true SE503179C2 (sv) 1996-04-15

Family

ID=22561419

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8900565A SE503179C2 (sv) 1988-02-18 1989-02-17 Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför
SE9300595A SE9300595A0 (sv) 1988-02-18 1993-02-23 Förfarande för framställning av antihyperkolesterolemiska medel

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE9300595A SE9300595A0 (sv) 1988-02-18 1993-02-23 Förfarande för framställning av antihyperkolesterolemiska medel

Country Status (32)

Country Link
US (1) US4824959A (de)
JP (2) JP2871707B2 (de)
KR (1) KR970002233B1 (de)
CN (1) CN1025619C (de)
AT (1) AT401057B (de)
AU (1) AU621586B2 (de)
BE (1) BE1002136A5 (de)
CA (1) CA1340430C (de)
CH (1) CH680792A5 (de)
CY (1) CY1874A (de)
DD (4) DD285600A5 (de)
DE (1) DE3904899A1 (de)
DK (1) DK75289A (de)
EG (1) EG19217A (de)
ES (1) ES2017810A6 (de)
FI (1) FI890725A (de)
FR (1) FR2630112B1 (de)
GB (1) GB2216121B (de)
GR (1) GR1000664B (de)
HK (3) HK129395A (de)
HU (2) HU209905B (de)
IE (1) IE65090B1 (de)
IT (1) IT1230750B (de)
LU (1) LU87456A1 (de)
MY (1) MY106279A (de)
NL (1) NL8900397A (de)
NO (1) NO172439C (de)
NZ (1) NZ227935A (de)
PT (1) PT89748B (de)
SE (2) SE503179C2 (de)
YU (1) YU34189A (de)
ZA (1) ZA891239B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244705B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE10147030A1 (de) * 2001-09-04 2003-03-27 Forschungszentrum Juelich Gmbh Verfahren zur Trennung diastereomerer 1,3-Diol-Acetale
WO2005107739A1 (en) * 2004-05-11 2005-11-17 Darley Pharmaceuticals Ltd. Spiroderivatives for the treatment of hypertension
US20050272808A1 (en) * 2004-05-11 2005-12-08 Nadav Zamir Compositions and methods for the treatment of hypertension
CN104303915B (zh) * 2014-08-25 2016-05-25 李世峰 一种机插水稻水浮式育秧技术

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225085A (ja) * 1982-06-24 1983-12-27 Nippon Kayaku Co Ltd アセタ−ルグリコ−ルジアクリレ−トおよびその製造法
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4751229A (en) * 1987-07-09 1988-06-14 Warner-Lambert Company Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
DE3807929A1 (de) * 1988-03-10 1989-09-28 Basf Ag Verfahren zur herstellung von reliefformen

Also Published As

Publication number Publication date
SE8900565D0 (sv) 1989-02-17
EG19217A (en) 1995-09-30
AU621586B2 (en) 1992-03-19
IE65090B1 (en) 1995-10-04
NO172439B (no) 1993-04-13
NO890661L (no) 1989-08-21
MY106279A (en) 1995-04-29
GB8903604D0 (en) 1989-04-05
NZ227935A (en) 1990-07-26
SE9300595D0 (sv) 1993-02-23
FR2630112A1 (fr) 1989-10-20
HUT50809A (en) 1990-03-28
DD283618A5 (de) 1990-10-17
CA1340430C (en) 1999-03-09
HUT50167A (en) 1989-12-28
GR1000664B (el) 1992-09-25
CN1036013A (zh) 1989-10-04
FR2630112B1 (fr) 1994-07-29
SE9300595A0 (sv) 1993-02-23
CN1025619C (zh) 1994-08-10
HK129295A (en) 1995-08-24
CH680792A5 (de) 1992-11-13
IT1230750B (it) 1991-10-29
GB2216121B (en) 1992-07-15
US4824959A (en) 1989-04-25
DD285602A5 (de) 1990-12-19
FI890725A (fi) 1989-08-19
KR970002233B1 (ko) 1997-02-26
KR890012992A (ko) 1989-09-20
NO172439C (no) 1993-07-21
CY1874A (en) 1996-04-05
GB2216121A (en) 1989-10-04
LU87456A1 (fr) 1989-09-20
DK75289A (da) 1989-08-19
IT8919474A0 (it) 1989-02-17
AU3007589A (en) 1989-08-24
JP2922887B2 (ja) 1999-07-26
NO890661D0 (no) 1989-02-16
ZA891239B (en) 1991-12-24
BE1002136A5 (fr) 1990-07-24
DD285603A5 (de) 1990-12-19
HU204045B (en) 1991-11-28
JPH01249771A (ja) 1989-10-05
ATA36189A (de) 1995-10-15
PT89748A (pt) 1989-10-04
AT401057B (de) 1996-06-25
HK129395A (en) 1995-08-24
FI890725A0 (fi) 1989-02-15
DD285600A5 (de) 1990-12-19
SE8900565L (sv) 1989-08-19
HU209905B (en) 1994-11-28
JP2871707B2 (ja) 1999-03-17
IE890523L (en) 1989-08-18
NL8900397A (nl) 1989-09-18
PT89748B (pt) 1994-05-31
DE3904899A1 (de) 1989-08-31
JPH115791A (ja) 1999-01-12
YU34189A (en) 1991-02-28
HK47596A (en) 1996-03-29
DK75289D0 (da) 1989-02-17
ES2017810A6 (es) 1991-03-01

Similar Documents

Publication Publication Date Title
SE503179C2 (sv) Framställning av antihyperkolesterolemiska tetrazol- föreningar och mellanprodukter härför
US5084569A (en) Trioxy bicyclic compounds useful for preparing optically active carboxylic acids
US4898950A (en) Preparation of antihypercholesterolemic tetrazole compounds
GB2244706A (en) Tetrazole intermediates
AT404724B (de) Neue zwischenverbindung und verfahren zur herstellung von antihypercholesterinämisch wirkenden tetrazolverbindungen
US5142066A (en) Stereoselective process for the preparation of 2-amino-ethanol derivatives having a central analgesic activity and intermidiates thereof
AT404725B (de) Verfahren zur herstellung antihypercholesterinämisch wirkender tetrazolverbindungen
JP2750874B2 (ja) （−）−３−（ｐ−トリル）グリシドール
NO174850B (no) 6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav
CZ286484B6 (en) 1,3-dioxan derivatives in cis-(4R,6S) form
IL105486A (en) Intermediate compounds for the preparation of anti-hypercholesterolemic compounds
IE65548B1 (en) Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
FI103886B (fi) Menetelmä aldehydivälituotteen valmistamiseksi
JPH08231469A (ja) シクロペンタンカルボン酸誘導体及びその製造法
Frye et al. Asymmetric Chemical Synthesis of (R)-and (S)-Citramalate in High Enantiomeric Purity
NO175636B (de)
JP2002114749A (ja) 光学活性２−ヒドロキシ−３−フェニルプロピオニトリル誘導体の製造法
JPS61205243A (ja) トレオ−α−置換β−ヒドロキシ酸アミドの製造方法
JPS61183232A (ja) （ｒ）−サントリナトリエンの製造方法
JPS6097989A (ja) 有機セレンおよび有機テルル誘導体

Legal Events

Date Code Title Description
NUG Patent has lapsed